Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 2 Testicular Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Liver Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Gemcitabine 54 130-nm albumin-bound paclitaxel 29 Magnetic Resonance Spectroscopy 21 Taxes 18 Fluorouracil 18 Specimen Handling 17 Oxaliplatin 17 Leucovorin 17 Drug Therapy 17 Albumin-Bound Paclitaxel 17 Irinotecan 14 pembrolizumab 13 Cyclophosphamide 11 Blood Specimen Collection 11 Biopsy 11 fludarabine 10 Radiosurgery 9 irinotecan sucrosofate 8 folfirinox 6 Magnetic Resonance Imaging 6 Cetuximab 6 Bevacizumab 6 dehydroftorafur 5 Surveys and Questionnaires 5 Nivolumab 5 Endoscopic Ultrasound-Guided Fine Needle Aspiration 5 sintilimab 4 olaparib 4 balstilimab 4 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pancreatic Neoplasms × Mesothelin × Clear all

NCT07066995 2025-07-15

BAH2573-102

Essen Biotech

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡